Article
Aldehyde dehydrogenase-2 inhibition blocks remote preconditioning in experimental and human models.
Basic research in cardiology - 1 May 2013
Contractor Hussain, Støttrup Nicolaj B, Cunnington Colin, Manlhiot Cedric, Diesch Jonathan, Ormerod Julian O M, Jensen Rebekka, Bøtker Hans Erik, Redington Andrew, Schmidt Michael R, Ashrafian Houman, Kharbanda Rajesh K
Abstract excerpt
Mitochondrial aldehyde dehydrogenase-2 (ALDH-2) is involved in preconditioning pathways, but its role in remote ischaemic preconditioning (rIPC) is unknown. We investigated its role in animal and human models of rIPC. (i) In a rabbit model of myocardial infarction, rIPC alone reduced infarct size [69 ± 5.8 % (n = 11) to 40 ± 6.5 % (n = 12), P = 0.019]. However, rIPC protection was lost after pre-treatment with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
